Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lemoli

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Experimental Hematology|November 14, 1997
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studiesM R Motta, S Mangianti, S Rizzi, et al.
Haematologica|June 19, 2001
Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patientsN Vianelli, L Valdrè, M Fiacchini, et al.
British Journal of Haematology|February 5, 1998
Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF)L Catani, L Gugliotta, E Campanini, et al.
Leukemia & Lymphoma|June 28, 2001
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cellsM T Petrucci, M R Ricciardi, C Gregorj, et al.
British Journal of Haematology|January 1, 1994
Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluationP L Tazzari, A Bolognesi, D De Totero, et al.
Blood|February 1, 1993
Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cellsR M Lemoli, T Igarashi, M Knizewski, et al.
British Journal of Haematology|July 23, 1998
Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+ cellsM Ratta, D Rondelli, A Fortuna, et al.
Experimental Hematology|December 1, 1995
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantationR M Lemoli, A Fortuna, M Fogli, et al.
European Journal of Haematology|March 1, 1989
Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell-associated antigens: effects on target cells and on normal myeloid precursors (CFU-GM)L Barbieri, A Dinota, M Gobbi, et al.
British Journal of Haematology|October 1, 1995
Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cellsR M Lemoli, M Fogli, A Fortuna, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Experimental Hematology|November 14, 1997
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studiesM R Motta, S Mangianti, S Rizzi, et al.
Haematologica|June 19, 2001
Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patientsN Vianelli, L Valdrè, M Fiacchini, et al.
British Journal of Haematology|February 5, 1998
Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF)L Catani, L Gugliotta, E Campanini, et al.
Leukemia & Lymphoma|June 28, 2001
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cellsM T Petrucci, M R Ricciardi, C Gregorj, et al.
British Journal of Haematology|January 1, 1994
Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluationP L Tazzari, A Bolognesi, D De Totero, et al.
Blood|February 1, 1993
Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cellsR M Lemoli, T Igarashi, M Knizewski, et al.
British Journal of Haematology|July 23, 1998
Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+ cellsM Ratta, D Rondelli, A Fortuna, et al.
Experimental Hematology|December 1, 1995
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantationR M Lemoli, A Fortuna, M Fogli, et al.
European Journal of Haematology|March 1, 1989
Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell-associated antigens: effects on target cells and on normal myeloid precursors (CFU-GM)L Barbieri, A Dinota, M Gobbi, et al.
British Journal of Haematology|October 1, 1995
Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cellsR M Lemoli, M Fogli, A Fortuna, et al.
Pageof 10